Delivery Order SPE2DB20D1100-SPE2DB25FD0B0
Award Date 6/20/25
Potential Completion Date 7/14/25
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,802.80 on August 1, 2025, for the supply of CABENUVA ER 600 mg-900 mg suspension in 6 mL units. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by August 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action under the company's...
- The Defense Logistics Agency awarded a $40,224.30 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension (6ml units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 2, 2026. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension (6 mL) with a ceiling value of $40,224.30 and a firm fixed price contract type. This delivery order is non-set-aside and will be completed by January 14, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,562.45 on December 11, 2025, for CABENUVA ER 600 MG-900 MG suspension (6 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance scheduled to conclude by January 5, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of CABENUVA ER 600 MG-900 MG suspension (6ML) under a firm fixed-price contract with a ceiling value of $3,816.90. This is a non-set-aside delivery order with an ultimate completion date of October 16, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of CABENUVA ER 600 MG-900 MG suspension in 6 mL quantities, valued at $38,169.00 under a firm fixed-price arrangement. This non-competitive set-aside delivery order will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $7,633.82 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 ml units. This firm fixed price delivery order, with an ultimate completion date of November 18, 2025, represents a non-set-aside competitive award. The product will be delivered to the company's headquarters in Conshohocken, Pennsylvania. Cabenuva is a long-acting injectable antiretroviral combination therapy...
- This delivery order, valued at $22,901.40, was awarded on August 7, 2025, by the Medical Supply Chain division of the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Cabenuva ER 600 mg-900 mg suspension (6 mL). The award represents a firm fixed-price, non-competitive delivery order with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from...
- The Defense Logistics Agency Medical Supply Chain awarded a $38,169 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for CABENUVA ER 600 MG-900 MG Suspension in 6 mL units. This firm fixed-price delivery order, which represents a child contract action under AmerisourceBergen's larger pharmaceutical supply agreements, is scheduled for completion by September 18, 2025, with performance at the company's Conshohocken, Pennsylvania location. The award was competitively awarded with...
- The Defense Logistics Agency awarded a $59,619.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 400 MG-600 MG suspension (4 mL), a long-acting injectable antiretroviral medication. The contract, issued on August 29, 2025, with ultimate completion by September 22, 2025, represents a non-competitive, non-set-aside award leveraging the vendor's existing DLA contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...